Sofosbuvir Patents

Given below is the list of patents protecting Sofosbuvir, along with the drug name that holds that patent and the company name owning that drug.

A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Sofosbuvir's patents.

Latest Legal Activities on Sofosbuvir's Patents

Given below is the list recent legal activities going on the following patents of Sofosbuvir.

Activity	Date	Patent Number
Today's Critical Events
Payment of Maintenance Fee, 8th Year, Large Entity	10 Jul, 2024	US9549941
Payment of Maintenance Fee, 4th Year, Large Entity	09 Jul, 2020	US9549941
Mail Certificate of Correction Memo	17 Apr, 2018	US9549941
Certificate of Correction Memo	11 Apr, 2018	US9549941
Recordation of Patent Grant Mailed Critical	24 Jan, 2017	US9549941
Patent Issue Date Used in PTA Calculation Critical	24 Jan, 2017	US9549941
Email Notification Critical	05 Jan, 2017	US9549941
Issue Notification Mailed Critical	04 Jan, 2017	US9549941
Application Is Considered Ready for Issue Critical	14 Dec, 2016	US9549941
Dispatch to FDC	14 Dec, 2016	US9549941

Sofosbuvir's Family Patents

Full family tree

Explore Our Curated Drug Screens

Sofosbuvir Generic API Manufacturers

Only one generic application has been filed for Sofosbuvir.

Given below is the list of companies who have filed for Sofosbuvir generic, along with the locations of their manufacturing plants worldwide.